On Wednesday, Wells Fargo made a notable adjustment to its stance on Ashland Inc . (NYSE:ASH), upgrading the chemical company's stock from Equal Weight to Overweight. Alongside the upgrade, the firm also increased Ashland's price target from $100.00 to $112.00. The revision reflects a positive outlook on the company's financial performance, anticipating a significant uptick in EBITDA growth for the fiscal year 2025.
Wells Fargo's analysis points to a robust earnings trajectory for Ashland in the second half of the fiscal year 2024, which is expected to fuel stronger EBITDA growth into the next fiscal year. The firm has raised its FY25 EBITDA estimate by $50 million to $575 million, indicating a year-over-year margin improvement of 310 basis points. This growth rate, which represents a 20% increase from the estimated figures for FY24, is seen as an underappreciated aspect of Ashland's financial evolution.
The upward revision in Ashland's stock rating and price target is supported by recent mergers and acquisitions that are believed to contribute to further multiple improvement. However, it is noted that Ashland's shares do not currently trade in alignment with its Flavor and Fragrance industry peers.
The analyst at Wells Fargo highlights a series of self-help measures and higher volumes as key drivers for margin improvement. An increase in margins from 14.8% in the first quarter of FY24 to an expected 26.8% by the fourth quarter of FY24 is seen as a positive catalyst for Ashland's stock. This improvement is attributed to better fixed cost absorption due to increased operating rates and the planned divestiture of Ashland's nutraceuticals business within its Life Sciences segment, which generates approximately $120 million in revenues.
The sale is anticipated to streamline the company's production network for hydroxyethyl cellulose (HEC), carboxymethyl cellulose (CMC), and microcrystalline cellulose (MC) businesses.
InvestingPro Insights
As investors assess Wells Fargo's optimistic upgrade of Ashland Inc., current data from InvestingPro provides a deeper financial context. The company's management has demonstrated confidence through an aggressive share buyback strategy, as one of the InvestingPro Tips points out. Additionally, Ashland's commitment to its shareholders is evident not only in its high shareholder yield but also in its consistent dividend growth, having raised its dividend for 5 consecutive years and maintained payments for an impressive 54 years.
From a valuation standpoint, Ashland's P/E ratio stands at 30, with an adjusted P/E ratio for the last twelve months as of Q1 2024 at 39.12, suggesting a high earnings multiple. This aligns with the InvestingPro Tips that highlight the company's trading at a high EBIT valuation multiple. Meanwhile, the company's revenue for the last twelve months as of Q1 2024 was reported at 2139M USD, with a gross profit margin of 28.1%. Despite a decline in revenue growth during the same period, Ashland's strong return over the last three months, at 17.63%, signals a positive market response.
For investors seeking comprehensive analysis and additional insights, there are more InvestingPro Tips available, which can be accessed with a special offer. Use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription. Discover more about Ashland's financial health and future prospects by visiting https://www.investing.com/pro/ASH, where 9 more tips await to guide your investment decisions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.